CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER THERAPY;
CHEMOEMBOLIZATION;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
DRUG INDICATION;
HISTOPATHOLOGY;
MEDICAL SOCIETY;
NEUROENDOCRINE TUMOR;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRACTICE GUIDELINE;
PROGNOSIS;
PROTEIN EXPRESSION;
TUMOR CLASSIFICATION;
TUMOR LOCALIZATION;
TUMOR VOLUME;
EDITORIAL;
ENDOCRINE TUMOR;
HUMAN;
NERVOUS SYSTEM TUMOR;
ENDOCRINE GLAND NEOPLASMS;
HUMANS;
NERVOUS SYSTEM NEOPLASMS;
NEUROENDOCRINE TUMORS;
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms
Brown KT, Koh BY, Brody LA, Getrajdman GI, Susman J, Fong Y & Blumgart LH 1999 Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. Journal of Vascular Intervention and Radiology 10 397-403.
Hepatic neuroendocrine metastases: Does intervention alter outcomes?
Chamberlain RS, Canes D, Brown KT, Saltz L, Jamagin W, Fong Y & Blumgart LH 2000 Hepatic neuroendocrine metastases: does intervention alter outcomes? Journal of American College of Surgery 190 432-445.
Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors
Hellman P, Ladjevardi S, Skogseid B, Akerstrom G & Elvin A 2002 Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World Journal of Surgery 26 1052-1056.
Streptozotocin-doxorubicin, streptozotocin-fluoro, or chlorozotocin in the treatment of advanced islet-cell carcinoma
Moertel CG, Lefkoponto M & Lipoty M 1992 Streptozotocin-doxorubicin, streptozotocin-fluoro, or chlorozotocin in the treatment of advanced islet-cell carcinoma. New England Journal of Medicine 326 519-513.
Treatment of carcinoid syndrome: A prospective crossover evaluation of Lanreotide versus Octreotide in terms of efficacy, patient acceptability, and tolerance
O'Toole D, Ducreux M, Bommelaer G, Wemeau JL, Bouche O, Catus F, Blumberg J & Ruszniewski P 2000 Treatment of carcinoid syndrome: a prospective crossover evaluation of Lanreotide versus Octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 88 770-776.
The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic implications of the concept
Pearce AGE 1969 The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic implications of the concept. Journal of Histochemistry and Cytochemistry 17 303-313.
